A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy
Clinical trial NCT06351904 · RECRUITING
Trial details
- NCT number
- NCT06351904
- Sponsor
- Ractigen Therapeutics.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-03
- Primary completion
- 2028-08-31
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.